U.S. Senators Baldwin and McCain to President Trump: Hold the Pharmaceutical Industry Accountable for Skyrocketing Prescription Drug Prices
WASHINGTON, D.C. – U.S. Senators Tammy Baldwin (D-WI) and John McCain (R-AZ) today sent a letter to President Trump urging him to hold the pharmaceutical industry accountable and make good on his promise to lower the skyrocketing prescription drug costs that American families are struggling to afford.
“We have offered a simple bipartisan solution that holds the pharmaceutical industry accountable and institutes basic transparency,” the senators continued. “We stand ready to work with you and our colleagues in Congress to address skyrocketing prescription drug prices so that American families can finally be afforded the relief they so desperately need.”
Senators Baldwin and McCain co-authored the FAIR Drug Pricing Act, which would address skyrocketing prescription drug prices and hold pharmaceutical companies accountable by requiring transparency for pharmaceutical corporations that plan to increase drug prices. The bill would not prohibit manufacturers from increasing prices, but it would, for the first time, give taxpayers notice of price increases and bring basic transparency to the market for prescription drugs.
The full letter is available here.
An online version of this release is available here.
NOTE: This press release was submitted to Urban Milwaukee and was not written by an Urban Milwaukee writer. While it is believed to be reliable, Urban Milwaukee does not guarantee its accuracy or completeness.
Mentioned in This Press Release
Recent Press Releases by U.S. Sen. Tammy Baldwin
Baldwin Calls on Trump Administration to Reverse Denial of Disaster Aid for Wisconsin
Aug 20th, 2026 by U.S. Sen. Tammy BaldwinBaldwin supports Governor Evers’ appeal for hazard mitigation funds to ensure Wisconsin communities can build back more resilient after April storms
Baldwin, Colleagues Introduce Bill to Stop Trump From Hiding Troop Death and Injuries From Iran War
Aug 14th, 2026 by U.S. Sen. Tammy BaldwinLegislation comes after Pentagon recategorized recent casualties suffered in Trump’s Iran War in an attempt to downplay war’s harms
Baldwin, Blumenthal Lead Colleagues in Demanding Trump Admin Rescind Cancelation of Lifesaving Research Grants That Improve Patient Safety & Care
Aug 14th, 2026 by U.S. Sen. Tammy BaldwinLawmakers: “The agency’s actions over the last year are an outrageous abuse of administrative power that will leave Americans sicker, poorer, and dying from preventable causes. Each of these canceled grants put real life patients further from the care that they need.”












